Immunointervention in Autoimmune Diseases. Papers Based on an International Meeting in Paris, France, in June 1988

Content: 
Front Matter, Page iii
Copyright, Page iv
Introduction, Pages 1-2, JEAN HAMBURGER
The Role of Antigen in Autoimmune Responses with Special Reference to Changes in Carbohydrate Structure of IgG in Rheumatoid Arthritis, Pages 3-10, Ivan M. Roitt, Raymond A. Dwek, Rajesh B. Parekh, Thomas W. Rademacher, Azita Alavi, John S. Axford, Katherine B. Bodman, Angela Bond, Anne Cooke, Frank C. Hay, David A. Isenberg, Peter M. Lydyard, Lorna Mackenzie, Graham Rook, Mark Smith, Nazira Sumar
Autoimmunity: the Moving Boundaries Between Physiology and Pathology, Pages 11-22, François Huetz, Frédéric Jacquemart, Claudia Peña Rossi, Francisco Varela, António Coutinho
Cyclosporine A and the Regulation of Autoimmune Disease, Pages 23-36, Kevin J. Lafferty, Lyndee L. Paris
Hazards of Cyclosporine A Therapy and Recommendations for its Use, Pages 37-47, Michael J. Mihatsch, Gil Thiel, Bernhard Ryffel
Cancer is a Long-term Hazard of Immunosuppressive Therapy, Pages 49-62, Israel Penn
Some Viral Infections and Related Disorders Associated with Long-term Immunosuppressive Treatments, Pages 63-77, Jean-François Nicolas, Grégoire Cozon, Jean-Pierre Revillard
Approach to the Use of Antigen Non-specific Immunosuppression in Systemic Lupus Erythematosus and Other Rheumatic Autoimmune Diseases, Pages 79-96, Alfred D. Steinberg, Dennis M. Klinman, Arthur M. Krieg, Michael F. Seldin, Daniel L. Kastner
Immunointervention in Skin Disorders, Pages 97-105, Lionel Fry
Therapeutic Immunosuppression in Type I (Insulin-dependent) Diabetes, Pages 107-118, Gilles Feutren, Christian Boitard, Roger Assan, Jean-François Bach
The Clinical Use of Immunosuppressants in the Treatment of Putative Autoimmune Intra-ocular Diseases, Pages 119-125, Robert Nussenblatt
A Theoretical Framework for Self-tolerance and its Relevance to Therapy of Autoimmune Disease, Pages 127-133, Herman Waldmann, Steve Cobbold, Richard Benjamin, Shixin Qin
Clinical Use of OKT3: The Role of Cytokine Release and Xenosensitization, Pages 135-144, Lucienne Chatenoud, Christiane Ferran, Christophe Legendre, Paul Franchimont, Aimée Reuter, Henri Kreis, Jean-François Bach
The Multichain Interleukin-2-Receptor: A Target for Immunotherapy of Patients with Adult T-cell Leukemia, Autoimmune Disorders and Individuals Receiving Allografts, Pages 145-157, Thomas A. Waldmann
Anti-IL-2-R Monoclonal Antibody in Allograft Recipients, Pages 159-165, J.P. Soulillou, B. Le Mauff, D. Cantarovich, M. Giral, M. Hourmant, Y Jacques
Therapy of Autoimmune Diseases with Monoclonal Antibodies to Class II Major Histocompatibility Complex Antigens: The Role of T Lymphocytes, Pages 167-175, C. Boitard, J.F. Bach
Idiotype Selection is an Immunoregulatory Mechanism which Contributes to the Pathogenesis of Systemic Lupus Erythematosus, Pages 177-185, Bevra H. Hahn, Fanny M. Ebling, Niver Panosian-Sahakian, Joan Klotz, Mitchell Kronenberg, Betty Tsao, Kenneth C. Kalunian, Dale G. Ando
Induction of SLE-like Disease in Naive Mice with a Monoclonal Anti-DNA Antibody Derived from a Patient with Polymyositis Carrying the 16/6 ID, Pages 187-195, M. Blank, S. Mendelovic, E. Mozest, Y. Shoenfeld
Cellular Mechanisms in Immune Tolerance and Treatment of Autoimmune Disease: Studies Using Total Lymphoid Irradiation (TLI), Pages 197-206, Samuel Strober, M. Carmen Fariñas
Maintenance of Autoimmunity, Pages 207-213, Norman Talal
The Risk/benefit Ratio in Immunointervention for Autoimmune Diseases, Pages 215-224, Jean-François Bach